Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared Matthew Herper’s, Senior Writer, Medicine, and Editorial Director, Events at STAT, post on X, adding:
“Accurately reflects recent and future challenges at US FDA.
There is certain urgency, need for less controversy, drama, conflicts or bias to correct the course.
One can also hope for a new chapter that is competent, forward-looking, science/evidence-based, trustworthy, more transparent and collaborative with the administration, but ultimately dedicated to public service to fulfill the agency’s mission.
What the Trump administration wants in its next FDA leader.”
Quoting Matthew Herper’s post:
“What the Trump administration wants in its next FDA leader via STAT.”
Other articles featuring Wafik S. El-Deiry and Matthew Herper on OncoDaily.